NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $62,000 | -60.0% | 212,800 | -14.7% | 0.00% | – |
| Q2 2015 | $155,000 | -17.1% | 249,500 | -7.9% | 0.00% | – |
| Q1 2015 | $187,000 | +55.8% | 270,800 | +42.6% | 0.00% | – |
| Q4 2014 | $120,000 | +8.1% | 189,900 | +43.8% | 0.00% | – |
| Q3 2014 | $111,000 | +258.1% | 132,100 | +234.4% | 0.00% | – |
| Q2 2014 | $31,000 | +47.6% | 39,500 | +159.9% | 0.00% | – |
| Q2 2013 | $21,000 | – | 15,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbitronix, LP | 17,664 | $35,000 | 0.03% |
| GLENMEDE TRUST CO NA | 300,000 | $30,000 | 0.00% |